Get the Stockscreener App
1.62
1.25%
0.02
Cerus Corp stock is traded at $1.62, with a volume of 1.02M.
It is up +1.25% in the last 24 hours and up +2.53% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.60
Open:
$1.54
24h Volume:
1.02M
Relative Volume:
0.76
Market Cap:
$310.55M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-7.7143
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
-5.26%
1M Performance:
+2.53%
6M Performance:
+29.60%
1Y Performance:
-10.00%
1-Day Range:
$1.54
$1.6489
1-Week Range:
$1.54
$1.78
52-Week Range:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.62 | 307.34M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
130.59 | 224.77B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
102.69 | 155.63B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
362.22 | 142.80B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
95.87 | 123.31B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
86.30 | 49.97B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Acadian Asset Management LLC Has $3.71 Million Stake in Cerus Corporation $CERS - MarketBeat
Will Cerus Corporation stock reach Wall Street targetsAnalyst Upgrade & Breakout Confirmation Alerts - newser.com
Why Cerus Corporation (CU2) stock stays resilientPortfolio Risk Report & Fast Gaining Stock Reports - newser.com
Why Cerus Corporation (CU2) stock attracts wealthy investorsEntry Point & Short-Term Trading Opportunity Alerts - newser.com
Why Cerus Corporation (CU2) stock appears on watchlists2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com
How Cerus Corporation (CU2) stock responds to job market shifts2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-11-15 00:38:10 - newser.com
How Cerus Corporation (CU2) stock trades pre earningsWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Published on: 2025-11-14 16:27:37 - newser.com
Can Cerus Corporation stock hit analyst price targetsMarket Movers & Real-Time Buy Zone Alerts - newser.com
Real time pattern detection on Cerus Corporation stockTrade Entry Report & High Conviction Trade Alerts - newser.com
Why retail investors favor Cerus Corporation stockWatch List & Consistent Return Investment Signals - Fundação Cultural do Pará
Why Cerus Corporation stock is trending among retail tradersTrade Entry Report & Expert Curated Trade Setups - Fundação Cultural do Pará
Published on: 2025-11-13 23:13:18 - newser.com
Will Cerus Corporation (CU2) stock outperform small cap peersJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Nothing is Better Than Cerus Corp (CERS) stock at the moment - setenews.com
Why Cerus Corporation stock is popular among millennialsEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
3 Promising Penny Stocks With Market Caps Under $400M - Yahoo Finance Singapore
Is Cerus Corporation reversing from oversold territoryPortfolio Risk Report & Weekly High Potential Alerts - newser.com
Is Cerus Corporation stock a buy for dividend growthLayoff News & Accurate Intraday Trading Signals - newser.com
Cerus Corporation (NASDAQ:CERS) Q3 2025 Earnings Call Transcript - Insider Monkey
Cerus (NASDAQ:CERS) Raised to Buy at Wall Street Zen - Defense World
Cerus Corporation’s Q3 2025 Earnings: Growth Amid Challenges - TipRanks
Cerus (NASDAQ:CERS) Announces Quarterly Earnings Results - MarketBeat
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
2.78%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):